Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $1.09 per share a year ago.

Viridian Therapeutics ( (VRDN)) has issued an update. Viridian Therapeutics, a biotech company, highlights its recent advancements in treating thyroid eye disease (TED) and FcRn inhibitor ...

Viridian Therapeutics, Inc.'s VRDN-001, now Veligrotug, shows promising phase 3 data in Thyroid Eye Disease, outperforming Tepezza in early stages and targeting both active and chronic TED. VRDN ...

If scientists can crack the code using lasers, it could lead to a virtually limitless supply of safe, sustainable energy without any carbon emissions. This month, construction crews are breaking ...

Israel expects its “Iron Beam” laser defense system to be operational within one year, saying it will bring “a new era of warfare” as it engages in a war of drones and missiles with Iran ...

A newly developed air defense laser has 100 percent of incoming threats during a new trial, the U.K. government has said, as several militaries forge ahead with efforts to get lasers operational ...

My team and I put the best laser engravers to the test - and these are the models we recommend for home crafting, hobbyists, and professionals. Like the best 3D printers we've reviewed ...

Viridian Advisory’s Brett Arnol has detailed how the firm is fostering the next generation of advisers through its Professional Year (PY) program. Viridian was established in 2015 and has more than ...

Researchers have uncovered the scale of two ancient cities buried high in the mountains of Uzbekistan. The cities were thought to be there, but their extent was unknown, so the team used drone ...